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Otte Brosjö1,2 and Panagiotis Tsagozis1,2*Abstract
Introduction: Aneurysmal bone cysts are benign tumours that usually present in childhood. Aggressive forms have
been described, which are often treated with surgery that entails major resection and reconstruction. Polidocanol
sclerotherapy has recently been reported to have excellent results and promises to replace operative treatments,
but its efficacy in the case of aggressive aneurysmal bone cysts has not been documented.
Case presentation: An 18-year-old woman from Sweden presented with pain in her shoulder and a rapidly progressing
cystic bone lesion. The differential diagnosis was a rare, aggressive form of aneurysmal bone cyst or a sarcoma of the
proximal humerus. She was successfully treated using sequential percutaneous injections of polidocanol after exclusion
of malignancy.
Conclusions: Management of aggressive aneurysmal bone cysts has thus far relied on open surgery. We propose that
non-operative treatment with polidocanol is efficient even in the aggressive form of the aneurysmal bone cyst.
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Aneurysmal bone cysts (ABCs) demonstrate a spectrum
of clinical presentations, from the latent to the active form
and finally the rare aggressive variant [1]. The latter is
sometimes extremely difficult to differentiate from tel-
angiectatic osteosarcoma. A variety of treatments is avail-
able for ABCs, ranging from curettage (with or without
filling of the cavity with polymethylmethacrylate) or au-
tologous en block excisions with reconstruction of the
skeletal defect with autograft or allograft, cryosurgery, se-
lective embolization of the feeding arteries or radiation
[1-4]. Most authors have relied on a more radical resection
and subsequent reconstruction of the skeletal defect in
order to treat aggressive ABCs [5-8]. Healing has also been
achieved by selective arterial embolization [9] or radio-
therapy, combined or not with cryosurgery [1,10].
Polidocanol sclerotherapy is a safe and effective treat-
ment method [11,12] that has gained popularity among* Correspondence: tsagozis@gmail.com
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ment of aggressive ABCs has not been reported. We report
for the first time in the medical literature the successful
non-operative treatment of an aggressive ABC using poli-
docanol sclerotherapy.
Case presentation
An 18-year-old woman from Sweden was admitted to
our institution due to a painful mass in her left shoulder,
discovered 2 months ago, and impairment in range-of-
motion (ROM). An ultrasound examination by the admit-
ting primary care physician revealed a vascularized tumour.
During physical examination, a palpable mass was present
in close proximity to her deltoid muscle. A plain X-ray
examination of her left humerus showed an osteolytic
lesion (Figure 1a) and magnetic resonance imaging (MRI)
revealed a 5.5cm tumour which had a discrete soft tissue
component (Figure 1b). Fine needle aspiration biopsy was
inconclusive, most suggestive of myositis ossificans. Over-
all, telangiectatic osteosarcoma could not be excluded, a
fact that led us to an open biopsy. The pathology report
verified the diagnosis of ABC, without any evidence of ma-
lignancy. A repeat MRI, approximately 6 weeks after theCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Plain radiograph of the patient showed an osteolytic lesion in the proximal humeral diaphysis (a), whereas magnetic resonance
imaging revealed an expansile tumour that occupied the medullary cavity and gave rise to a soft tissue component (b).
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the intraosseous and the extraosseous components of the
tumour, raising again the suspicion of sarcoma (Figure 2).
This led to a second open biopsy, and the second pathology
report was also consistent with an ABC. The diagnosis of
an unusually aggressive ABC was set, and polidocanol
sclerotherapy was initiated. She received six consecutive
injections of 240mg of polidocanol under general anaes-
thesia and fluoroscopic guidance at approximately 3-weekFigure 2 Repeat magnetic resonance imaging 6 weeks after the
initial one, showing considerable growth of both the intraosseous
as well as the soft tissue component of the aneurysmal bone cyst
(approximately 30% and 300% respectively).time intervals (Figure 3a), until symptoms subsided and
convincing radiological findings of healing of the lesion
were observed. She had no symptoms at follow-up 3
months after the last injection, and her shoulder ROM
was normalized. She remains symptom-free 1.5 years after
the last injection, and there is radiologic consolidation of
the lesion (Figure 3b).
Discussion
ABCs demonstrate a spectrum of clinical presentations,
from the latent to the active form and finally the rare ag-
gressive variant. The latter is sometimes extremely difficult
to differentiate from telangiectatic osteosarcoma, as our
case also clearly demonstrates. Referral to dedicated sar-
coma centres, where clinical findings, radiology, cytology
and pathology are interpreted by a multidisciplinary team
offer clear advantages as far as diagnosis and therapy are
concerned.
The biological aggressiveness of the lesion should be taken
into account when choosing therapy, the more indolent
forms can be treated with minimally invasive approaches or
even observed, because there is a potential of spontaneous
regression. As intralesional excisions have been associated
with higher recurrence rate than wide excision, most
authors have relied on a more radical resection and subse-
quent reconstruction of the skeletal defect to treat aggres-
sive ABCs.
The presented case suggests that the non-invasive treat-
ment with polidocanol is equally effective in aggressive
ABCs, is not accompanied by side effects and seems to
compare favourably to surgery. Indeed, morbidity associ-
ated to radical surgery is not negligible, time to recovery is
Figure 3 Fluoroscopy picture taken during the 5th injection of polidocanol, showing proper placement of the needle and signs of sclerosis
(a), and graphical reconstruction of a computed tomography scan of the proximal humerus, 18 months after the last treatment, showing
consolidation of the lesion (b).
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been reported [5]. Other methods also have drawbacks:
selective arterial embolization is technically demanding
and not applicable to all cases as the lesions often lack
defined feeding vessels and radiotherapy carries the risk
for development of late sarcomas [10]. Polidocanol sclero-
therapy is, according to our experience [13] and previously
published data [11,12], a simple and safe treatment that
can be performed on an out-patient basis, with no serious
side effects and with very high efficacy.Conclusions
We suggest that polidocanol sclerotherapy be considered
a treatment option for all ABCs, including the aggressive
lesions. This is an important finding because it shows the
applicability of a simple non-operative method for the treat-
ment of a disease, which previously entailed open surgery
with a considerable risk for side effects.Consent
Written informed consent was obtained from the patient
for the publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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